Page last updated: 2024-11-09

6-phenylthiouracil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-phenylthiouracil: inhibits production of thyroxine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID697057
CHEMBL ID1212975
CHEBI ID182773
SCHEMBL ID1006272
MeSH IDM0167659

Synonyms (75)

Synonym
HMS1473P14
AKOS005451230
6-phenyl-2-thioxo-2,3-dihydro-1h-pyrimidin- 4-one
BB 0242494
6-phenyl-2-sulanylidene-1h-pyrimidin-4-one
CHEBI:182773
CHEMBL1212975
CBCHROMO1_000231
nsc42600
nsc-42600
IDI1_019662
CBDIVE_012254
6-phenyl-2-thioxo-1h-pyrimidin-4-one
6-phenyl-2-thioxo-2,3-dihydropyrimidin-4(1h)-one
CHEMDIV3_000344
36822-11-4
nsc-163991
nsc163991
6-phenyl-2-thiouracil, >=95%
SR-01000636416-1
6-phenyl-2-thioxo-2,3-dihydro-4(1h)-pyrimidinone
NCGC00175843-01
STK382461
6-phenyl-2-sulfanylpyrimidin-4(1h)-one
6-phenylthiouracil
AC-10796
AKOS000111876
BRD-K26169329-001-01-0
6-phenyl-2-sulfanyl-4-pyrimidinol
AC-907/34127061
6-phenyl-2-sulfanylidene-1h-pyrimidin-4-one
2-mercapto-6-phenylpyrimidin-4-ol
F0043-0080
2-mercapto-6-phenylpyrimidin-4(3h)-one
F2135-0911
6-phenyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one
4-hydroxy-2-mercapto-6-phenylpyrimidine
6-phenyl-2-thiouracil
P0236
STL102641
CCG-605
STK574454
6-phenyl-2-sulfanylpyrimidin-4-ol
6-phenyl-2-thioxo-1h-pyrimidin-4-one;2-mercapto-6-phenylpyrimidin-4-ol
A823385
AKOS005208337
AKOS005203242
einecs 253-227-4
nsc 163991
nsc 42600
ai3-26584
4(1h)-pyrimidinone, 2,3-dihydro-6-phenyl-2-thioxo-
UW68300000
niosh/uw6830000
2-mercapto-4-phenyl-6-pyrimidinol
6-pyrimidinol, 2-mercapto-4-phenyl-
FT-0639342
2-mercapto-6-phenyl-pyrimidin-4-ol
SCHEMBL1006272
2-mercapto-6-hydroxy-4-phenylpyrimidine
2-mercapto-4-hydroxy-6-phenylpyrimidine
AS-5217
W-202521
bariumethylsulfate
6-phenyl-2-thioxo-2,3-dihydro-4(1h)-pyrimidinone #
BS-4149
mfcd00059166
DTXSID80190291
2,3-dihydro-2-thioxo-6-phenylpyrimidin-4(1h)-one
6-phenyl-2-thiouracil, analytical standard
2-mercapto-6-phenylpyrimidin-4-one
mfcd00465574
SB60659
CS-W013194
EN300-152778
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyrimidinesAny compound having a pyrimidine as part of its structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Taste receptor type 2 member 38Homo sapiens (human)EC50 (µMol)0.50000.00491.36102.3000AID1619468
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Taste receptor type 2 member 38Homo sapiens (human)Activity0.15000.15003.256310.0000AID1619467
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
detection of chemical stimulus involved in sensory perception of bitter tasteTaste receptor type 2 member 38Homo sapiens (human)
G protein-coupled receptor signaling pathwayTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
G protein-coupled receptor activityTaste receptor type 2 member 38Homo sapiens (human)
bitter taste receptor activityTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneTaste receptor type 2 member 38Homo sapiens (human)
membraneTaste receptor type 2 member 38Homo sapiens (human)
membraneTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID497621Inhibition of DNA double strand break-induced ataxia telangiectasia mutated activation in Xenopus laevis extract assessed as inhibition of H2AX phosphorylation2008Nature chemical biology, Feb, Volume: 4, Issue:2
A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.34 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]